Rothschild & CO Asset Management Us Inc. Intercept Pharmaceuticals, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$24.48 - $42.47 $5.43 Million - $9.41 Million	-221,611 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$39.09 - $53.44 $1.53 Million - $2.1 Million	-39,229 Reduced 15.04%	221,611 $9.19 Million
Q2 2020 Aug 10, 2020	BUY	$46.7 - $92.04 $12.2 Million - $24 Million	260,840 New	260,840 $12.5 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.